171482-05-6,MFCD13183776
Catalog No.:AA00HZGV

171482-05-6 | (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$47.00   $33.00
- +
5g
97%
in stock  
$124.00   $87.00
- +
10g
97%
in stock  
$239.00   $167.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00HZGV
Chemical Name:
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride
CAS Number:
171482-05-6
Molecular Formula:
C20H19ClF7NO2
Molecular Weight:
473.8122
MDL Number:
MFCD13183776
SMILES:
Fc1ccc(cc1)[C@@H]1NCCO[C@@H]1O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C.Cl
Properties
Properties
 
Form:
Solid  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
526  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Downstream Synthesis Route
252742-72-6   
2R-2α(R*),3α-2-1-3,5-bis(trifluoromethyl)phenylethoxy-3-(4-fluorophenyl)morpholinehydrochloride 
  170729-80-3 

[1]JournaloftheAmericanChemicalSociety,2003,vol.125,p.2129-2135

[1]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[2]CurrentPatentAssignee:MERCK&COINC-WO2003/89429,2003,A1Locationinpatent:Page/Pagecolumn7-8

[1]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN103030668,2016,BLocationinpatent:Paragraph0037;0038

[2]CurrentPatentAssignee:HAINANXINKAIYUANPHARMATECH-CN112939885,2021,ALocationinpatent:Paragraph0046-0065

[3]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[4]CurrentPatentAssignee:SHANDONGLUKANGPHARMACEUTICALCO.,LTD.-CN110746371,2020,ALocationinpatent:Paragraph0127-0161

171482-05-6   
CASUnavailable 

[1]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[1]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[2]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[3]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:171482-05-6 Molecular Formula|171482-05-6 MDL|171482-05-6 SMILES|171482-05-6 (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride
Catalog No.: AA00HZGV
171482-05-6,MFCD13183776
171482-05-6 | (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride
Pack Size: 1g
Purity: 97%
in stock
$47.00 $33.00
Pack Size: 5g
Purity: 97%
in stock
$124.00 $87.00
Pack Size: 10g
Purity: 97%
in stock
$239.00 $167.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00HZGV
Chemical Name: (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride
CAS Number: 171482-05-6
Molecular Formula: C20H19ClF7NO2
Molecular Weight: 473.8122
MDL Number: MFCD13183776
SMILES: Fc1ccc(cc1)[C@@H]1NCCO[C@@H]1O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C.Cl
Properties
Form: Solid  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 526  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 3  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 31  
Hydrogen Bond Acceptor Count: 10  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Downstream Synthesis Route
252742-72-6   
2R-2α(R*),3α-2-1-3,5-bis(trifluoromethyl)phenylethoxy-3-(4-fluorophenyl)morpholinehydrochloride 
  170729-80-3 

[1]JournaloftheAmericanChemicalSociety,2003,vol.125,p.2129-2135

171482-05-6    155742-64-6    219821-37-1 

[1]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[2]CurrentPatentAssignee:MERCK&COINC-WO2003/89429,2003,A1Locationinpatent:Page/Pagecolumn7-8

352-13-6    287930-75-0    171482-05-6 

[1]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN103030668,2016,BLocationinpatent:Paragraph0037;0038

[2]CurrentPatentAssignee:HAINANXINKAIYUANPHARMATECH-CN112939885,2021,ALocationinpatent:Paragraph0046-0065

[3]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[4]CurrentPatentAssignee:SHANDONGLUKANGPHARMACEUTICALCO.,LTD.-CN110746371,2020,ALocationinpatent:Paragraph0127-0161

171482-05-6   
CASUnavailable 

[1]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

30071-93-3    171482-05-6 

[1]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[2]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

[3]Brands,KarelM.J.;Payack,JosephF.;Rosen,JonathanD.;Nelson,ToddD.;Candelario,Alexander;Huffman,MarkA.;Zhao,MatthewM.;Li,Jing;Craig,Bridgette;Song,ZhiguoJ.;Tschaen,DavidM.;Hansen,Karl;Devine,PaulN.;Pye,PhilipJ.;Rossen,Kai;Dormer,PeterG.;Reamer,RobertA.;Welch,ChristopherJ.;Mathre,DavidJ.;Tsou,NancyN.;McNamara,JamesM.;Reider,PaulJ.[JournaloftheAmericanChemicalSociety,2003,vol.125,#8,p.2129-2135]

Building Blocks More >
1782220-15-8
1782220-15-8
tert-Butyl N-[(2-methylpiperidin-3-yl)methyl]carbamate
AA00HZPW | MFCD24532556
180205-27-0
180205-27-0
Cyclobutaneethanol, 1-(aminomethyl)-
AA00HZY0 | MFCD22391928
1807503-91-8
1807503-91-8
2-(T-Butoxycarbonylamido)-1,3-bis (t-butoxycarbonylethoxy)propane
AA00I04C | MFCD28505566
1820574-99-9
1820574-99-9
6-tert-butyl 1-methyl (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hexanedioate
AA00I0AR | MFCD27578431
1820640-81-0
1820640-81-0
N-BOC-3-(1-tosyloxyethyl)azetidine
AA00I0JN | MFCD28143965
1820684-20-5
1820684-20-5
2-(3-Bromophenyl)piperidine HCl
AA00I0QP | MFCD26131162
1820716-87-7
1820716-87-7
N-(3-Nitropyridin-2-yl)methanesulfonamide
AA00I0YQ | MFCD28122688
1823835-67-1
1823835-67-1
Benzyl (azepan-3-ylmethyl)carbamate
AA00I17U | MFCD00153684
1845696-05-0
1845696-05-0
2-(2-Bromo-5-chlorophenoxy)acetohydrazide
AA00I1EW | MFCD28515396
1864062-45-2
1864062-45-2
5-[2-(Dimethylamino)ethoxy]-2-fluorobenzonitrile
AA00I1PX | MFCD29035401
Submit
© 2017 AA BLOCKS, INC. All rights reserved.